Prostate Cancer Essay

or boyfriend have cancer? Many people get scared. Male who goes to doctors office and find out that they have “prostate cancer”, get scared and think it's the end of the world, or starting to search, ask themselves why they have it or what can they do about it, and ect, but they do not research before having cancer to know what this is cancer about, how to prevent the cancer, or where it come from and why? Well, prostate cancer is cancer that begins in tissues of the male prostate gland and also called

Prostate cancer is the most common type of cancer in American men after skin cancer. There are many risk factors that increase the disease such as age, being the far most important risk factor, along with race, family history and diet (ASCO, 2015). The prostate is a walnut shaped gland of the male reproductive system that functions to create part of the semen, which is fluid in which sperm swim in when ejaculation occurs. It is located inferior to the bladder, anterior to the rectum, surrounding

Prostate Cancer The history of prostate cancer is basically a progression of disease from an asymptomatic to symptomatic for patients who have biochemical failure non metastatic disease to metastatic disease and castration sensitive to resist. Over the year, rapid development of number of new drugs that are now FDA approved. More the recent studies of chemo-naïve mCRPC or pre-docetaxel metastatic states, conducted in last 5 years. Early experienced with next generation AR-targeting agent quickly

Introduction Prostate cancer is one of the most common types of cancer in men. According to the American Cancer Society, “there are nearly 3 million prostate cancer survivors in the United States today and this number is expected to increase to almost 4.2 million by 2024. Most prostate cancers (93%) are diagnosed at the local or regional stage, before the cancer has spread to surrounding organs. Treatment at these early stages is often very successful, and the 5-year relative survival rate approaches

.2.1 Prostate Specific Antigen (PSA) PSA is a biomarker that is regularly used clinically for screening and diagnosis of prostate cancer. It was discovered in 1972 while trying to find a substance in seminal fluid that would aid in the research of medical cases. Papsidero and associates measured PSA quantitatively in the blood in 1980, which was stated to be a clinical use as a marker for prostate cancer. PSA exists in small quantities in the serum of normal men, and it is raised higher in the presence

Textbook answers 3 CT1. The prostate is a ridiculous organ, with a minimally-important function (secretion of prostatic fluid increases survival of sperm by a fraction), and a high propensity for developing cancer – I’d get rid of it altogether. The problem is that it’s a gland wrapped around a tube, and as you age it hypertrophies and prevents easy urination. Alternatively, if it were just a gland in proximity to the urethra, rather than encircling it, we could enjoy its few benefits without having

6.0 Understanding Prostate Cancer 6.1 A general discussion about prostate cancer in NZ This cancer is unusual in that it takes a long time (15-20 years or more) to progress from a localised state in the prostate to metastatic disease and death. Men whose cancer is in the localised state may have no prostate symptoms, no bleeding or pain. The tumour is too small to cause obstruction or LUTS (In older men coexisting BPH may cause LUTS, but there may be a cancer present too). Research on the incidence

The records have been reviewed. The member is an adult male with a birth date of 03/10/1960. He has a diagnosis of prostate cancer. His treating provider, Samuel Torres, MD, recommended the Oncotype DX Prostate Cancer Assay, which was performed on 12/30/2015. The carrier has denied coverage of Oncotype DX Prostate Cancer Assay as experimental and/or investigational and not medically necessary. A letter from the carrier to the provider, dated 06/22/2016, states in part: “Claim number 201602083184074

Prostate Cancer Eng 101 Andrell Nash Fortis College Abstract Prostate Cancer is a disease in which there is an uncontrolled growth of cells that lines the ducts of the prostate gland. The abnormal cells can spread throughout the prostate and nearby organs, such as the seminal vesicles. If not caught early they can spread (metastasized) to other organs of the body through the lymph or blood stream. (“...Treatment...” 13) Prostate Cancer can be like a silent killer. Some may show signs and symptoms

Background: Among various epithelial cancers, genomic studies of prostate cancer (PCa) identified several molecular markers including E26 transformation specific (ETS) gene fusions, SPINK1 and many others. The prevalence of these molecular markers in African American (AA) prostate cancer has not been studied to the extent that has been studied for European American (EA) prostate cancer to understand the racial disparity. Contrary to the conventional approaches, new approaches are needed to understand